Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial Fibrillation

Conditions: Atrial Fibrillation Interventions: Procedure: Rhythm control by Pulmonary Vein Isolation (PVI) procedure; Drug: Conventional care by antiarrhythmic drugs (flecainide, sotalol, amiodarone) or bradycardic drugs (all betablocker or calcium channel blocker therapy, digoxin) Sponsors: Nantes University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials